+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Studies on the Monoamine Oxidase (MAO)-Catalyzed Oxidation of Phenyl-Substituted 1-Methyl-4-phenoxy-1,2,3,6-tetrahydropyridine Derivatives: Factors Contributing to MAO-A and MAO-B Selectivity



Studies on the Monoamine Oxidase (MAO)-Catalyzed Oxidation of Phenyl-Substituted 1-Methyl-4-phenoxy-1,2,3,6-tetrahydropyridine Derivatives: Factors Contributing to MAO-A and MAO-B Selectivity



Journal of Medicinal Chemistry 38(11): 1904-1910



The structural parameters responsible for the substrate and inhibitor selectivities of the monoamine oxidases (MAO) A and B remain poorly understood. This situation has improved somewhat with structure-activity studies that have been performed on nuclear-substituted pargyline derivatives and 4-substituted 1-methyl-1,2,3,6-tetrahydropyridine derivatives. The results of these studies suggest that the active site of MAO-A is sterically more accommodating than the active site of MAO-B. In the present work we have undertaken a more systematic structure-substrate activity analysis with the aid of a series of 4-phenoxytetrahydropyridine analogs substituted at the para, meta, and ortho positions of the phenyl ring with chloro, methoxy, methyl, nitro, and phenyl groups. All of the compounds proved to be good substrates for both MAO-A and MAO-B, and all were better MAO-A substrates than MAO-B substrates. The best defined structural parameter relating to selectivity again was the relatively better MAO-A substrate properties of tetrahydropyridine derivatives bearing bulky C-4 substituents. Attempts to identify stereoelectronic effects related to substrate properties and selectivity with this series of compounds were not successful. Although some structural correlates with substrate activity can be made, overall the present state of knowledge is inadequate to provide good descriptors of structural features that characterize MAO-A and MAO-B substrates.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009475402

Download citation: RISBibTeXText

PMID: 7783122

DOI: 10.1021/jm00011a010


Related references

Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Medicinal Chemistry 39(19): 3694-3700, 1996

Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Journal of Medicinal Chemistry 28(10): 1432-1436, 1985

Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-Mpdp+, the monoamine oxidase catalyzed oxidation product of the nitrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Mptp). Journal of Medicinal Chemistry 28(10): 1432-1436, 1985

Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives. Journal of Pharmacology and Experimental Therapeutics 291(2): 856-864, 1999

Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B. Journal Of Medicinal Chemistry. 36(9): 1278-1283, 1993

Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives. Chemical Research in Toxicology 9(6): 1013-1022, 1996

Generation of reactive oxygen species during monoamine oxidase catalyzed oxidation of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. FASEB Journal 7(3-4): A697, 1993

Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Biological Chemistry 268(22): 16504-16512, 1993

The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chemical Research in Toxicology 10(4): 364-368, 1997

Why is the rat immune to 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine toxicity comparative studies of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine effect on striatal dopamine and monoamine oxidase b in mice and rats. Neurology 36(4 Suppl. 1): 97, 1986

Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal Of Neurochemistry. 62(5): 2012-2016, 1994

Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B. Journal of Neurochemistry 45(4): 1049-1054, 1985

Studies on the mechanism of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine oxidation by human liver monoamine oxidase b. S Letters: 100-102, 1986

Stopped flow studies on the mechanism of the oxidation of n methyl 4 phenyl 1 2 3 6 tetrahydropyridine mptp by monoamine oxidase. Edmondson, D E And D B Mccormick (Ed ) Flavins And Flavoproteins; Proceedings Of The Ninth International Symposium, Atlanta, Georgia, Usa, June 7-12, Xxiii+775p Walter De Gruyter And Co : Berlin, West Germany; Hawthorne, New York, Usa Illus 705-708, 1987

Studies on the monoamine oxidase-B-catalyzed biotransformation of 4-azaaryl-1-methyl-1,2,3,6-tetrahydropyridine derivatives. Journal of Medicinal Chemistry 42(10): 1828-1835, 1999